Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Viridian Financial Group secures TA Associates investment to expand Australian wealth services Viridian Financial Group partners with TA Associates to scale its wealth management business in Australia, targeting growth via M&A and innovation. byPallavi MadhirajuJuly 1, 2025